I Would Rebuild My Portfolio With Just These 3 Stocks If I Lost Everything Tomorrow

The article is a bullish, long-term portfolio commentary arguing that if the author had to rebuild from zero, they would buy NVIDIA, Eli Lilly, and Johnson & Johnson. NVIDIA is presented as the core growth engine, with Q1 FY27 revenue of $81.61 billion, 85% YoY growth, record free cash flow, and a major increase in shareholder returns via a larger dividend and $80 billion buyback. Eli Lilly is framed as a high-growth pharma franchise powered by Mounjaro and Zepbound, with Q1 revenue up 55.5% and raised full-year guidance. Johnson & Johnson is positioned as the defensive anchor, supported by a 64-year dividend growth streak, rising revenue, and upgraded guidance. The piece is not a trading alert but a conviction-driven stock-picking article emphasizing compound growth, cash generation, and dividend stability. Market impact is limited, but it reinforces bullish sentiment toward NVDA and LLY while highlighting JNJ as a lower-risk ballast amid broader market weakness.